About Molbio Diagnostics
Molbio Diagnostics is a company based in India founded in 2000 by Chandrasekhar Nair and Sriram Natarajan.. Molbio Diagnostics has raised $123.98 million across 4 funding rounds from investors including Motilal Oswal, Temasek and ACT Grants. The company has 616 employees as of April 20, 2024. Molbio Diagnostics has completed 1 acquisition, including Prognosys Medical Systems. Molbio Diagnostics offers products and services including Truenat and Truenat Assays. Molbio Diagnostics operates in a competitive market with competitors including DermTech, Inflammatix, Karius, MeMed and Visby Medical, among others.
- Headquarter Salcete, India
- Employees 616 as on 20 Apr, 2024
- Founders Chandrasekhar Nair, Sriram Natarajan
- Stage Unicorn
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Molbio Diagnostics Limited
- Date of Incorporation 20 Oct, 2000
- Jurisdiction Salcete, Goa, India
-
Annual Revenue
$40.57 M (USD)-56.83as on Mar 31, 2023
-
Net Profit
$-414.21 K (USD)-101.6as on Mar 31, 2023
-
EBITDA
$5.19 M (USD)-88.36as on Mar 31, 2023
-
Total Equity Funding
$123.98 M (USD)
in 4 rounds
-
Latest Funding Round
-
Investors
Motilal Oswal
& 4 more
-
Employee Count
616
as on Apr 20, 2024
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Molbio Diagnostics
Molbio Diagnostics offers a comprehensive portfolio of products and services, including Truenat and Truenat Assays. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Portable real-time PCR device for detecting multiple infectious diseases
Assays for use with Truenat platform to identify pathogens
Unlock access to complete
Unlock access to complete
Funding Insights of Molbio Diagnostics
Molbio Diagnostics has successfully raised a total of $123.98M across 4 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 4
- Last Round Last Round
-
First Round
First Round
(22 Jan 2020)
- Investors Count 5
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun, 2023 | Amount | Grant - Molbio Diagnostics | Valuation |
investors |
|
| Sep, 2022 | Amount | Series C - Molbio Diagnostics | Valuation | Temasek | |
| May, 2021 | Amount | Series B - Molbio Diagnostics | Valuation | Motilal Oswal |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Molbio Diagnostics
Molbio Diagnostics has secured backing from 5 investors, including venture fund, institutional, and angel investors. Prominent investors backing the company include Motilal Oswal, Temasek and ACT Grants. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Seed capital grants are provided to incubate and accelerate innovations.
|
Founded Year | Domain | Location | |
|
An investment platform is provided for diverse sectors and geographies.
|
Founded Year | Domain | Location | |
|
Motilal Oswal Alternates is engaged in alternative investment management.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Molbio Diagnostics
Molbio Diagnostics has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Prognosys Medical Systems. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
High-end medical devices for radiology and imaging are manufactured.
|
2003 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Molbio Diagnostics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Molbio Diagnostics Comparisons
Competitors of Molbio Diagnostics
Molbio Diagnostics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as DermTech, Inflammatix, Karius, MeMed and Visby Medical, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Adhesive patch biopsies for skin cancer detection are provided.
|
|
| domain | founded_year | HQ Location |
Provider of diagnostic solutions for systemic infections
|
|
| domain | founded_year | HQ Location |
Developer of a non-invasive pathogen blood test for the detection of infectious diseases
|
|
| domain | founded_year | HQ Location |
Provider of machine learning based diagnostic solutions for infectious diseases
|
|
| domain | founded_year | HQ Location |
Portable PCR diagnostics for infectious diseases are developed.
|
|
| domain | founded_year | HQ Location |
Instruments and test panels for multiplexed molecular diagnostics are provided.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Molbio Diagnostics
Frequently Asked Questions about Molbio Diagnostics
When was Molbio Diagnostics founded?
Molbio Diagnostics was founded in 2000 and raised its 1st funding round 20 years after it was founded.
Where is Molbio Diagnostics located?
Molbio Diagnostics is headquartered in India. It is registered at Goa, India.
Who is the current CEO of Molbio Diagnostics?
Sriram Natarajan is the current CEO of Molbio Diagnostics. They have also founded this company.
Is Molbio Diagnostics a funded company?
Molbio Diagnostics is a funded company, having raised a total of $123.98M across 4 funding rounds to date. The company's 1st funding round was a Series B of $19.25M, raised on Jan 22, 2020.
How many employees does Molbio Diagnostics have?
As of Apr 20, 2024, the latest employee count at Molbio Diagnostics is 616.
What is the annual revenue of Molbio Diagnostics?
Annual revenue of Molbio Diagnostics is $40.57M as on Mar 31, 2023.
What does Molbio Diagnostics do?
Developer of point-of-care molecular diagnostic platform for infectious disease detection. The solution includes Trueprep a fully automatic universal cartridge-based sample prep device, Prolab Atlus portable x-ray system, Thermalytix AI-based thermal scanning device, and Truelab, a real-time, quantitative micro-PCR analyzer that targets diseases like rifampicin resistance, COVID19, influenza, dengue, hepatitis, HPV, malaria, and others.
Who are the top competitors of Molbio Diagnostics?
Molbio Diagnostics's top competitors include Visby Medical, Inflammatix and DermTech.
What products or services does Molbio Diagnostics offer?
Molbio Diagnostics offers Truenat and Truenat Assays.
How many acquisitions has Molbio Diagnostics made?
Molbio Diagnostics has made 1 acquisition, including Prognosys Medical Systems.
Who are Molbio Diagnostics's investors?
Molbio Diagnostics has 5 investors. Key investors include Motilal Oswal, Temasek, ACT Grants, Motilal Oswal Alternates, and Shankar Gopalakrishnan.
What is Molbio Diagnostics's valuation?
The valuation of Molbio Diagnostics is $1.6B as of Sep 2022.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.